The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages
- 5 January 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 230 (1) , 9-14
- https://doi.org/10.1016/0014-2999(93)90403-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Tumor necrosis factor in the pathophysiology of infection and sepsisClinical Immunology and Immunopathology, 1990
- Cytokines and eicosanoids in rheumatic diseases.Annals of the Rheumatic Diseases, 1990
- Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 productionThe Lancet, 1990
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Theophylline and the immune response: In vitro and in vivo effectsClinical Immunology and Immunopathology, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Cytokines: Molecular and Biological CharacteristicsScandinavian Journal of Rheumatology, 1988
- Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral MalariaScience, 1987